Pediatrix Medical Group, Inc. (MD) Stock Analysis
Range Bound setup
Healthcare · Medical Care Facilities
Hold if already holding. Not a fresh buy at $23.01, but acceptable to hold if already in. Reasons: Concentration risk — Geographic: Texas (32.0%); Analyst target reached - limited upside remaining.
Pediatrix Medical Group provides physician services in newborn, maternal-fetal, and pediatric subspecialty care through approximately 2,295 affiliated physicians across 37 states, primarily staffing hospital-based NICUs. Revenue is earned from hospital and third-party payor... Read more
Hold if already holding. Not a fresh buy at $23.01, but acceptable to hold if already in. Reasons: Concentration risk — Geographic: Texas (32.0%); Analyst target reached - limited upside remaining. Chart setup: RSI 54 mid-range, Bollinger mid-band. Maintain position. Not compelling to add more. Score 5.7/10, moderate confidence.
Passes 6/8 gates (clean insider activity, no SEC red flags, news events none recent, earnings proximity 77d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: aggressive.
Recent Developments — Pediatrix Medical Group, Inc.
Latest news
- Here's why Pediatrix Medical Group (MD) is a strong momentum stock - MSN — MSN positive
- A Look Back at Healthcare Providers & Services Stocks’ Q4 Earnings: Pediatrix Medical Group (NYSE:MD) Vs The Rest Of The — Yahoo Finance positive
- Phocas Financial Corp. Acquires 103,328 Shares of Pediatrix Medical Group, Inc. $MD - MarketBeat — MarketBeat positive
- Is Pediatrix Medical Group Inc (MD) Overvalued After 3.7% Rally? - GuruFocus — GuruFocus neutral
- Pediatrix Medical Group (MD) Is Up 13.7% After Beating EPS and Reaffirming EBITDA Outlook - Has The Bull Case Changed? - — simplywall.st positive
Generated 2026-05-20T20:21:21Z.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHGeographicTexas32%10-K Item 1A: 'Texas accounted for approximately 32% of our net revenue in 2025'
Material Events(8-K, last 90d)
- 2026-05-07Item 5.02LOWShareholders approved the Second Amended and Restated 2008 Incentive Compensation Plan at the 2026 Annual Meeting, increasing shares available by 8,000,000. Routine compensatory arrangement amendment.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
10 dimensions · all in-band
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $23.01, but acceptable to hold if already in. Reasons: Concentration risk — Geographic: Texas (32.0%); Analyst target reached - limited upside remaining. Chart setup: RSI 54 mid-range, Bollinger mid-band. Maintain position. Not compelling to add more. Target $23.87 (+3.7%), stop $21.40 (−7.5%), A.R:R -0.8:1. Score 5.7/10, moderate confidence.
Take-profit target: $23.87 (+3.7% upside). Target $23.87 (+3.7%), stop $21.40 (−7.5%), A.R:R -0.8:1. Stop-loss: $21.40.
Concentration risk — Geographic: Texas (32.0%); Analyst target reached - limited upside remaining; V7 low-quality RISK_OFF penalty: -0.5 (Q=5.2).
Pediatrix Medical Group, Inc. trades at a P/E of 11.0 (forward 9.6). TrendMatrix value score: 7.9/10. Verdict: Hold.
15 analysts cover MD with a consensus score of 3.9/5. Average price target: $23.
What does Pediatrix Medical Group, Inc. do?Pediatrix Medical Group provides physician services in newborn, maternal-fetal, and pediatric subspecialty care through...
Pediatrix Medical Group provides physician services in newborn, maternal-fetal, and pediatric subspecialty care through approximately 2,295 affiliated physicians across 37 states, primarily staffing hospital-based NICUs. Revenue is earned from hospital and third-party payor reimbursement; Texas accounted for approximately 32% of net revenue in 2025.